MétaCan
Menu
Back to cohort

RECIST (Response Evaluation Criteria in Solid Tumors) applied to response in lymphoma

2004· article· en· W2339464282 on OpenAlexaffabout
Sarit Assouline, E. Eisenhauer

Bibliographic record

VenueJournal of Clinical Oncology · 2004
Typearticle
Languageen
FieldMathematics
TopicStatistical Methods in Clinical Trials
Canadian institutionsOntario Institute for Cancer Research
Fundersnot available
KeywordsMedicineResponse Evaluation Criteria in Solid TumorsNuclear medicineClinical trialCruCancerTarget lesionInternal medicinePhases of clinical research

Abstract

fetched live from OpenAlex

6606 Background: RECIST utilizing unidimensional tumor measures are widely accepted for assessing response in solid tumor clinical trials. We have investigated whether these criteria can be applied to response assessment in lymphoma. However, to do so, complete response (CR) criteria were modified to include the following: a) baseline node(s) >15 mm must regress to ≤15 mm; b) nodes 10–15 mm must regress to normal; and c) enlarged spleen or liver is non-measurable and must return to normal size. Further, CR unconfirmed (CRu) by IWC was considered PR by RECIST. Methods:Using RECIST with these modifications, we determined clinical response in three phase II lymphoma trials of the National Cancer Institute of Canada Clinical Trials Group and compared results with response as determined by the International Working Criteria (IWC) (Cheson B, JCO 1999). Kappa estimated agreement of response (CR+PR+CRu) and non-response (PR+SD) between RECIST and IWC. Pearson's coefficient estimated correlation between changes in uni- and bidimensional measurements for responses based on these measurements alone. Results: 115 pts were evaluable, 92 with non-Hodgkin's and 23 with Hodgkin's lymphoma. By IWC, 14 achieved CR, 2 CRu, 32 PR, 52 SD, 15 PD, for an overall response (OR) of 42%. By RECIST, there were 14 CR, 39 PR, 47 SD, 15 PD, and OR 46%. κ=0.81 (95% CI: 0.70, 0.91), Pearson's r=0.81(95% CI: 0.71, 0.88) for changes in uni- and bidimensional measurements (n=75) for the two instruments. Conclusions: After some adaptations, applying RECIST to lymphoma yields near identical OR as IWC. There is high agreement between responses determined using uni- and bidimensional measurements. The benefits of RECIST over IWC include: familiarity among cancer trialists, simplicity of measuring unidimensional disease and providing follow-up measurements only for nodes >15 mm at baseline, and ability to include patients whose lymphoma is extranodal only. RECIST do not include CRu as a response category but OR is the likely estimate of interest in phase II clinical trials of novel agents. We therefore propose adapted RECIST be further studied for assessment of response in lymphoma. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.023
metaresearch head score (Gemma)0.023
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.023
Threshold uncertainty score0.119

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0230.023
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0050.004
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.715
GPT teacher head0.698
Teacher spread0.016 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2004
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicStatistical Methods in Clinical TrialsFrench-language works237,207